Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase
Authors
Keywords
-
Journal
BIOCHEMICAL JOURNAL
Volume 463, Issue 3, Pages 413-427
Publisher
Portland Press Ltd.
Online
2014-09-02
DOI
10.1042/bj20140889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- INPP4B: the New Kid on the PI3K Block
- (2015) Irina U. Agoulnik et al. Oncotarget
- Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors
- (2013) Eeva M. Sommer et al. BIOCHEMICAL JOURNAL
- Class III phosphatidylinositol 3-kinase and its catalytic product PtdIns3P in regulation of endocytic membrane traffic
- (2013) Camilla Raiborg et al. FEBS Journal
- Regulation of Mammalian Autophagy by Class II and III PI 3-Kinases through PI3P Synthesis
- (2013) Kelly Devereaux et al. PLoS One
- Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors
- (2012) Ayaz Najafov et al. BIOCHEMICAL JOURNAL
- SGK3 is associated with estrogen receptor expression in breast cancer
- (2012) Jun Xu et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting the PI3K signaling pathway in cancer therapy
- (2012) Chandra Bartholomeusz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma
- (2012) Ming Liu et al. HEPATOLOGY
- Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function
- (2012) Kazuaki Yoshioka et al. NATURE MEDICINE
- PI3K signalling: the path to discovery and understanding
- (2012) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy
- (2011) Thomas Farkas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor
- (2011) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1
- (2010) Ayaz Najafov et al. BIOCHEMICAL JOURNAL
- Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
- (2010) P. Workman et al. CANCER RESEARCH
- PI3KC2 , a class II PI3K, is required for dynamin-independent internalization pathways
- (2010) C. Krag et al. JOURNAL OF CELL SCIENCE
- The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt In Cancer Cells with Overactivated Akt
- (2010) Y. Li et al. MOLECULAR CANCER THERAPEUTICS
- SGK3 Is an Estrogen-Inducible Kinase Promoting Estrogen-Mediated Survival of Breast Cancer Cells
- (2010) Yuanzhong Wang et al. MOLECULAR ENDOCRINOLOGY
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Beclin 1–VPS34 complex – at the crossroads of autophagy and beyond
- (2010) Sarah F. Funderburk et al. TRENDS IN CELL BIOLOGY
- The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease
- (2009) Lisa M. Ooms et al. BIOCHEMICAL JOURNAL
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes
- (2009) Anne Simonsen et al. JOURNAL OF CELL BIOLOGY
- The nuts and bolts of AGC protein kinases
- (2009) Laura R. Pearce et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Regulation of phosphoinositide 3-kinase expression in health and disease
- (2009) Klaartje Kok et al. TRENDS IN BIOCHEMICAL SCIENCES
- Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition
- (2009) Véronique Calleja et al. PLOS BIOLOGY
- The regulation and function of Class III PI3Ks: novel roles for Vps34
- (2008) Jonathan M. Backer BIOCHEMICAL JOURNAL
- mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
- (2008) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- Cell-cycle-dependent binding kinetics for the early endosomal tethering factor EEA1
- (2008) Trygve Bergeland et al. EMBO REPORTS
- The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†
- (2008) Adrian J. Folkes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Membrane recognition by phospholipid-binding domains
- (2008) Mark A. Lemmon NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search